Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Sian Lazell

Sian joined the Animal Pharm team in February 2015 after graduating with a degree in English Literature with Psychology from Bath Spa University.

Sian writes about emerging start-up companies and new research from academia. She is especially interested in the pet health space, as well as the introduction of digital technology for both companion animals and livestock. She also has an interest in increasing Animal Pharm's equine coverage, as she owns horses herself.

In addition to covering animal health news and conducting interviews with worldwide companies, Sian also works on the evolving Animal Pharm Product Approvals Index.
Set Alert for Articles By Sian Lazell

Latest From Sian Lazell

Antech selects ex-Henry Schein CEO as new president

Antech Diagnostics has appointed a new president to lead its diagnostics and sound operations.


OIE notified of first AHS outbreak in Asia

African horse sickness (AHS) virus has been reported in Thailand – the first time the it has been detected in Asia. 

Thailand Equine

Askel reports crowdsourcing success for cartilage scaffold technology

Medical technology firm Askel Healthcare has bagged a significant amount of funding via crowdsourcing.

Investments R&D

AMA works to secure veterinary drug supply, agricultural operations to keep moving

Animal Medicines Australia (AMA) has assured industry it is working to maintain an uninterrupted supply of veterinary medicines and animal health products.  

Australia Operations

EMA report outlines extent of MUMS classifications in last decade

The European Medicines Agency (EMA) has revealed there have been 22 minor use/minor species (MUMS) authorizations for veterinary medicines over the last decade. 

Product Approvals Pharmaceuticals

Intervacc preclinical mastitis vaccine work backed by Vinnova funding

Intervacc has been awarded funding from Sweden's governmental innovation agency Vinnova to further develop a vaccine against mastitis.

Vaccines Bovine
See All